Research News New appointments within Scientific Career Path

3 September 2024

The Radboudumc Executive Board recently announced various appointments of researchers within the Radboudumc Scientific Career Path: one as Associate Professor and Research Group Leader; four as researcher in Talent Track phase 1 (TT1), and two as Assistant professor in the Talent Track phase 2 (TT2). 

We would proudly like to introduce these talented researchers to you. 

Associate Professor and Research Group Leader

Iris Walraven (dept. IQ Health)

Iris Walraven   was appointed Associate Professor and Research Group Leader. The main aim of her research line is to tailor cancer care to the risks and needs of the individual patient. Iris’ research is focused The main aim of the research line of the candidate is focused on prognostic epidemiology and oncology and has strong clinical relevance.
Main research program: Thoracic Oncology. 

Assistant professors in TT2

Martijn van den Bosch (dept. Rheumatology)
Martijn van den Bosch’s research addresses an important clinical topic as Osteoarthritis is the most common joint disease and is/will become a chronic disease. The candidate focusses on understanding molecular mechanisms of rheumatic diseases, part osteoarthritis and rheumatoid arthritis. He has a unique niche in synovial inflammation.
Main research program: Chronic Inflammatory Diseases: from disease characteristics to
precision medicine

Jonne Doorduin (dept. Intensive Care)
Jonne Doorduin’s research addresses an important clinical topic benefitting
patients (less morbidity and mortality) and society (costs). He contributes to improving respiratory support and reduction of detrimental effects of ICU treatment on
patients and reducing ICU stay duration.
Main research program: Neuromuscular disorders


Researchers in TT1

Rob Arts (dept. Internal Medicine)
Rob Arts’s research addresses important topics of infectious
diseases, including application of the concept Trained immunity to severe
and HIV-associated infections. He aims to advance the field and improve patient
outcomes.
Main research program: Innate immunity in health and diseases

Marjolijn Duijvestein (dept. MDL)
Marjolijn Duijvestein’s research on optimizing IBD (Inflammatory bowel disease) treatment and sustainability in MDL/IBD care. It is a chronic disease affecting patients of all ages, causing inflammation of the intestinal tract., where etiology is not known.  She plans to focus on  interplay between immunology, genetics, microbiome, and other environmental and lifestyle factors.  Additionally, she created a niche on sustainability: Green Practices in Gastroenterology.
Main research program: Chronic inflammatory diseases (CID): from disease characteristics
to precision medicine

Maria Victoria Luna Velez (dept. Urology)
Maria Victoria Luna Velez works in field of  genitourinary cancer systems biology with the ultimate goal of advancing knowledge on PCa ( prostate cancer) biology and to generate data that can direct clinical interventions by two different approaches: unbiased and targeted. The unbiased approach will address the disease’s molecular complexity by interrogating and integrating systems-wide data through experimental biology and computational analysis. Her targeted research focus lies on specific molecules or pathways to elucidate mechanisms of action and outline potential clinical applications. 
Main research program: 3D biology and disease mechanisms. 

Maaike van Bergen (dept. Laboratory Medicine)
Maaike van Bergen’s research addresses the important topic of clonal hematopoiesis as a premalignant condition to hematological cancers. She focuses on identifying factors that drive leukemia development, to ultimately target/inhibit these factors and thereby prevent the transformation towards leukemia, and can be used as a biomarker for selecting potential patients. 
Main research program: Treatment improvement for severe hematological disease  


About the Scientific Career Path

The Scientific Career Path is the first of three Academic Career Paths that has been developed, approved and implemented at Radboudumc. The other Academic career paths, with an Education & Training or Academic Healthcare profile, are currently being developed- all in line with the national Recognition and Rewards Initiative. 

The Scientific Career Path consists of a talent track – a trajectory for researchers from postdoc to Associate Professor -and Research Group Leader (RGL) – and a career track for researchers from Associate Professor-RGL to full Professor-RGL level. 

We distinguish two stages in the Talent Track - research profile: 

-    Phase 1: for researchers at postdoc level with several years of experience. At the end of this phase, which covers maximum 5 years, successful candidates are promoted to assistant professor with a  research profile. 
-    Phase 2: After a positive evaluation candidates enter the second phase. Upon successful completion of this second phase, they will be appointed as Associate Professor - Research Group Leader. In this second phase the Hypatia scheme, for external candidates,  is also included.

The Talent Track Committee evaluates all candidates with a research profile and advises the Radboudumc Executive Board about appointments within Talent Track 1, 2 and towards Associate professor-RGL. 


Read more about the Scientific Career Path: https://www.radboudumc.nl/en/intranet/research/scientific-career-path 


 

Related news items